News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Thor Halfdanarson: The risk of recurrence following resection of pNETs
mayoclinic.org
Nov 1, 2024, 12:08

Thor Halfdanarson: The risk of recurrence following resection of pNETs

Thor Halfdanarson, Vice President at the North American Neuroendocrine Tumor Society, shared on X:

“This is going to be a favorite paper in the clinic when counseling patients on risk of recurrence following resection of pNETs. Node negativity and absence of lymphovascular invasion predict a very favorable outcome and low recurrence risk.”

Thor Halfdanarson

Incidence and Prognostic Implications of Lymphovascular Invasion in Node-Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study Group

Authors: Kota Sahara, Diamantis I. Tsilimigras, Yuki Homma, Jun Kawashima, Shishir K. Maithel, Flavio Rocha, Sharon Weber, Ryan Fields, Kamran Idrees, George A. Poultsides, Cliff Cho, Itaru Endo, Timothy M. Pawlik

Thor Halfdanarson

More posts featuring Thor Halfdanarson.

 

cancer Cliff Cho Diamantis I. Tsilimigras Flavio Rocha George A. Poultsides Itaru Endo Jun Kawashima Kamran Idrees Kota Sahara OncoDaily oncoology Ryan Fields Sharon Weber Shishir K. Maithel Thor Halfdanarson Timothy M. Pawlik Yuki Homma
Special Coverage
Opinion
Nov 1, 2024, 12:08
Thor Halfdanarson: The risk of recurrence following resection of pNETs
Opinion
Nov 1, 2024, 11:51
Huiping Liu: Intriguing LSBC24 session and debate on Tailoring Local Therapy
Blog
Nov 1, 2024, 11:28
Sherene Loi: Long-Term affects of Adjuvant Breast Cancer Treatment on Lymphocyte Counts
Blog
Nov 1, 2024, 10:27
How ovarian cancer hampers immune cells by cutting off their energy supply? - Cancer Research Institute
Insight
Nov 1, 2024, 08:06
Vérane Achard: Our editorial on the long-term results of the RTOG 0712
Blog
Nov 1, 2024, 08:03
Stephen Liu: Discussion on first-line management of EGFR NSCLC with Zosia Piotrowska
Blog
Nov 1, 2024, 07:37
Paolo Tarantino: ADCs combine the potency of chemotherapy with the PK of mAbs
Blog
Nov 1, 2024, 07:32
Gabriela Kramer-Marek: New imaging technique Identifies Brain Tumour Patients for Immunotherapy
Blog
Nov 1, 2024, 07:28
Wenora Johnson: Honored to share The 2024 Scopy Award with Charles R. Rogers
Blog
Nov 1, 2024, 07:21
Yaky Yanay: Pluri will be collaborating with BIRAD to advance cancer immunotherapy for solid tumors
Blog
Nov 1, 2024, 06:47
Mukhtasar Alkali: Celebrating 10 Years of Walk Away Cancer NG
Blog
Nov 1, 2024, 06:42
Luis Raez: Begining lung cancer awareness with the visits to Memorial Cancer Institute